405 filings
Page 3 of 21
20-F/A
7bij3
4 Mar 19
Annual report (foreign) (amended)
7:05am
6-K
63mz450 kj7
1 Mar 19
Primary Document
12:00am
424B3
7cilgqb53
26 Feb 19
Prospectus supplement
5:25pm
424B3
wxp2lzk
26 Feb 19
Prospectus supplement
5:21pm
6-K
p57pc4yyjad
22 Feb 19
Primary Document
5:24pm
424B3
6rdd4szj
20 Feb 19
Prospectus supplement
8:12am
424B3
lm05zybhdva5y8qzbz9r
20 Feb 19
Prospectus supplement
8:10am
6-K
njvcww6
20 Feb 19
Primary Document
8:06am
SC 13G/A
z3ljdj
14 Feb 19
Intellipharmaceutics International Inc.
2:31pm
SC 13G/A
2i1xe f7kdxg
14 Feb 19
Intellipharmaceutics International Inc.
1:44pm
424B3
4vfle9v
4 Feb 19
Prospectus supplement
5:49pm
424B3
b2h29z bxjjg285
4 Feb 19
Prospectus supplement
5:49pm
6-K
6061a7mm
4 Feb 19
Intellipharmaceutics Appoints New Chief Financial Officer
5:10pm
SC 13G/A
996pzoj2 9r
1 Feb 19
Intellipharmaceutics International Inc.
3:48pm
SC 13G/A
sffm7e51pnm65bq 9mj
29 Jan 19
Intellipharmaceutics International Inc.
3:40pm
SC 13G
v31hzt9 76dn
29 Jan 19
Intellipharmaceutics International Inc.
3:30pm
424B3
zrolcit0g286keznu
28 Jan 19
Prospectus supplement
5:14pm
424B3
9jxajfxj
28 Jan 19
Prospectus supplement
5:11pm
6-K
ff0j3 2mh
28 Jan 19
Intellipharmaceutics Receives Extension from Nasdaq Hearings Panel
5:06pm